Orgãos Sociais

Senior Lecturer in Health Economics in the Division of Health Research at Lancaster University, United Kingdom. She holds a PhD in Public Health-Health Economics from the National School of Public Health, Nova University of Lisbon in Portugal, an MSc in European Social Policy Analysis from Bath University in the UK, and graduated in Economics from ISEG – Lisbon School of Economics and Management, Lisbon University in Portugal. Between 2001 and 2014 she was Assistant Professor of Health Economics at the National School of Public Health at University Nova of Lisbon. She worked for the Institute of Management and IT (Ministry of Health) in the Department of Information Systems Development from 1995 until 2000, where she was the Executive responsible for the Financing System/Classification System in Diagnoses Related Groups. She has over 20 years of experience in research and has developed her expertise around economic evaluation of health technologies, efficiency measurement, equity and quality of life. She has been involved in several scientific associations in the field of health care such as PCSI, EuHEA and the Portuguese Chapter of ISPOR. She has done a wide variety of consultancy work for private and public entities, both in Portugal and abroad.

Associate Professor at Católica Porto Business School, Universidade Católica Portuguesa.He holds a PhD and a MSc in Economics from the University of York (UK) and graduated in Economics from Instituto Superior de Economia e Gestão (UTL, Portugal). His main areas of expertise are microeconomics, auction theory and competition policy and regulation and it is in these areas that he teaches several courses at the undergratuate and postgraduate level. Specifically in Health Economics, he has developed academic work mainly in the pharmaceutical sector. He has done a wide variety of consultancy work for private and public entities, both in Portugal and abroad, on several topics related to regulation and competition in the telecommunications, financial services and health sectors (among others).

Education

MSc in Economic Evaluation for Health Technology Assessment (at the University of York). Before Post-graduation Certification on Epidemiological Methodology (Lisbon University of Pharmacy), MSc in Health Services Management (Business School, University Institute of Lisbon), and Degree in Economics (Lisbon School of Economics and Management).

Work experience

Centre for Health Evaluation & Research (CEFAR / ANF), Health Economics Project Manager: Economic and Pharmacoeconomic studies, Pricing & Reimbursement, Economic Evaluation.

Before Health Economist at INFARMED (Economic and Observatory Departments), Representative in international projects (“Pharmaceutical Pricing and Reimbursement Information – PPRI”, “European Surveillance of Antimicrobial Consumption” funded by the European Commission) and national projects as Directorate-General for Health Consultant (for the execution and implementation of public health policies).

Publications/ Other Activities

Co-author in more than 10 articles published in indexed journals (The European Journal of Health Economics, Expert Review of Pharmacoeconomics & Outcomes Research, International Journal of Clinical Pharmacy, BMC Health Services Research, Frontiers in Pharmacology, Acta Médica Portuguesa, Revista Portuguesa de Cardiologia).

Research Abstract Review Committee of the International Society for Pharmacoeconomics and Outcomes Research.

Lecture in Pharmacoeconomics courses (Portuguese Pharmaceutical Society, Institute of Health Sciences – Catholic University of Portugal).

Portuguese Observatory on Health Systems researcher: National School of Public Health (ENSP), Lisbon University of Pharmacy, University of Coimbra – Centre for Health Studies and Research (CEISUC), Évora University.

Elected Member (Treasurer) of Board of Directors, of the Portuguese Association for Health Economics.

Ana Moura is a PhD candidate in Economics at Tilburg University, the Netherlands. In her research, she uses microeconometric techniques to study a variety of topics within health economics. Some of her current projects include identifying the sources of regional variation in healthcare expenditures, quantifying the effects of retailer price competition in the market for over-the-counter pharmaceuticals, and analyzing the impact of changes in geographic access to healthcare providers on both patient outcomes and hospital processes.
Ana holds a Master as well as a first degree in Economics from Nova School of Business and Economics. She is affiliated with the Health Economics & Management Knowledge Center at Nova School of Business and Economics.

PhD candidate in Economics at Nova School of Business and Economics. Invited Assistant for Global Economics and visiting researcher at the Boston University and at the Harvard School of Public Health.

Luís Filipe is a PhD student at Nova School of Business and Economics. His research interests are twofold:

Ageing of the population and informal care

Doctors’ behavior and hospital efficiency in systems with non-financial incentives

https://sites.google.com/view/luiscoelhofilipe

Sara Machado is a Fellow at the Department of Health Policy at the London School of Economics. She is also the Harvey Chair Scholar in Brigham and Women’s Hospital in Boston. She teaches courses in health economics, with a focus on policy applications of fundamental economic concepts, on the Department’s full-time master’s programme and executive education.

She acts as an adviser to national and international organisations, including the Portuguese Ministry of Health and the European Observatory on Health Systems and Policy. She co-authored the Health Systems in Transition – Portugal 2011 country profile and the Strategy for to Eliminate Hepatitis C in Portugal, in 2017.

Sara Machado is committed to building bridges between researchers, policy-makers, and health care practitioners. She is the Deputy Chair of the Early Career Committee of the European Health Economics Association and a member of the Management Board of BEHnet, an international network of researchers and practitioners conducting behavioural experiments in health.

Phd candidate in Global Public Health at Escola Nacional de Saúde Publica of Nova University of Lisbon. His main research areas are health economics, ageing and evaluation of public policies.

Member of the Health Technology Assessment Commission of the Portuguese National Authority of Medicines and Health Products (INFARMED)

BSc in Economics at University of Alicante (2013), Double MSc “Economic Development and Growth” at University of Warwick and Lund University (2015).

Paula Veiga is an auxiliary professor at the University of Minho and member of NIMA-  Microeconomics applied research group.  Paula holds a PhD in economics from University of South Carolina. Her research interest is focussed on applied microeconomic analysis, especially on health related topics.

Luis Nobre Pereira is professor at the University of Algarve. He holds a Licenciatura in Mathematics Applied to Economics and Management (ISEG – University of Lisbon), a MSc in Statistics and Information Management (NOVAIMS – New University of Lisbon), and a PhD in Quantitative Methods Applied to Economics and Management (University of Algarve).

His current research interests include Econometric Modelling and Data Analysis applied to Health Economics: outcomes Research; measurement of health related quality of life (HRQoL); valuing and modelling health; modelling stated preference data; and health state utilities. He is author of about 30 scientific papers published in academic journals with scientific refereeing, including the Value in Health, the Quality of Life Research, the European Journal of Health Economics and the Journal of Applied Statistics.

Work Experience:

Currently Health Economics & Outcomes Research consultant on Center for Evidence Based

Medicine (CEMBE), Faculdade de Medicina, Universidade de Lisboa (since September 2016).

Major work experience and publications are related to Health Technologies Assessment
projects and to Health Economics research, since 2006.
As a health economist, previous work was developed in the Research Centre on the
Portuguese Economy (CISEP, ISEG/UL). Lecturer experience on Economic Evaluation of Drugs
and Pharmacoeconomics post-graduation courses on ISEG and Faculdade de Farmácia (UL) was
also carried out from 2008 to 2012 and additional previous experiences were carried as
external consultant for National Authority of Medicines and Health Products, IP (Infarmed) and
as a reviewer for International Society for Pharmacoeconomics and Outcomes Research (ISPOR
conferences and Value in Health).

Education:
MSc in Health Economics, Policy and Management (London School of Economics &
Management, 2011)
MSc in Economics (NOVA School of Business & Economics, 2007)

Francisca Vargas Lopes is a PhD Candidate at the Public Health Department of the Erasmus Medical Center (EMC), within a project with joint supervision from the Erasmus School of Economics (ESE – Health Economics). The aim of her PhD is to identify policies with the potential to reduce health inequalities in developed countries, by performing impact evaluation and using microeconometrics methods.

In 2017 Francisca completed an MSc in International Health Policy and Health Economics at the London School of Economics and Political Science (LSE), writing her Master’s dissertation on the performance of Accident and Emergency (A&E) departments in England. In between completing her Masters and pursuing her PhD she worked in health services research at the Nuffield Trust and as an Outcomes Consultant for Pfizer UK.

Francisca’s previous working experience includes roles in HTA, outcomes research, and pharmacoepidemiology, at Merck Sharp & Dohme Portugal, the Center for Evidence Based Medicines of the Faculty of Medicine of the University of Lisbon (CEMBE) and the Center for Health Evaluation and Research (CEFAR – ANF), respectively. Francisca graduated as a Pharmacist (M.Pharm) in 2013 from the Faculty of Pharmacy of the University of Lisbon.

Mónica Inês joined Instituto de Medicina Molecular at Faculty of Medicine (University of Lisbon) to complete her PhD in Science & Health Technologies. She holds an MSc in Applied Econometrics and Forecast and a BSc in Applied Mathematics to Economics and Management both awarded by the University of Lisbon (ISEG).

Mónica has more than 20 years of experience related to the application of health economics, namely health technology assessment and econometric empirical analysis of epidemiological, health related quality of life and resource use/costs data. Mónica started her career in the National Authority of Medicines and Health Products (INFARMED) and is currently Outcomes & Evidence Senior Manager at Pfizer.

She is also Health Economics Applied Econometrics invited professor at ISEG, University of Lisbon. Mónica is furthermore the elected-president of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Portugal Regional Chapter.

PhD candidate in Health Economics at Nova School of Business and Economics. Research fellow at the European Training Network “Improving Quality of Care in Europe”.

Judite Gonçalves is a researcher and teaching assistant at Nova School of Business and Economics (SBE) in Carcavelos, nearby Lisbon, Portugal. She is a member of the Nova SBE Health Economics and Management Knowledge Center (NHEM). Her research interests are mainly in the fields of Health economics and Aging. She teaches Statistics, Econometrics, and Health Economics. Previously, she held research positions at Queen Mary, University of London (QMUL), UK, and at the Geneva School of Economics and Management (GSEM), University of Geneva, Switzerland, where she got her PhD in Econometrics in 2015.